Delivery Order SPE2DB22D1106-SPE2DB25FEJK7
Award Date
4/18/25
Potential Completion Date
4/21/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D3101|SPE2DB24FRBE2) from the Defense Logistics Agency (DLA) for the supply of Prilosec DR 2.5 mg Suspension, valued at $12,325.17. The contract has a ceiling value of $12,325.17 and an ultimate completion date of February 9, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
This federal contract award, with an ID of SPE2DB22D1200|SPE2DB24FN0PK, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Prilosec DR 2.5 mg suspension, a medication used for various gastrointestinal conditions. The award has a ceiling value of $2,758.93 and is a firm fixed-price delivery order contract with a completion date of February 2, 2024. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Prilosec DR 2.5 mg suspension, a medical product, with a ceiling value of $1,974.48 and a period of performance through November 16, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.17 firm fixed-price contract is for the supply of Prilosec DR 10 mg suspension medication, with a completion date of December 24, 2024. This contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Prilosec DR 2.5 mg suspension 30s to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $2,105.68, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award is for the delivery of Prilosec DR 10 mg suspension in 30-count packages to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract, valued at $1,599.48, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on May 22, 2024, with a completion date of May 23, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award, with ID SPE2DB20D3101|SPE2DB23FRYD6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $54,180.05 Firm Fixed Price contract is for the delivery of Prilosec DR 10 mg suspension medication. The contract has a completion date of September 20, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,708.16 firm fixed-price delivery order is for the supply of Prilosec DR 10 mg suspension to support military healthcare programs. The contract has an ultimate completion date of January 15, 2025 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,808.82, is for the supply of Prilosec DR 10 mg suspension medication. The contract has an ultimate completion date of December 12, 2023 and is a firm fixed price delivery order. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, with ID SPE2DB20D3101|SPE2DB23FRYE3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $25,395.84 firm-fixed-price delivery order is for the supply of Prilosec DR 10 mg suspension in 30-count packages. The contract has an ultimate completion date of September 20, 2023. The award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug...